The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
Related Posts
Quantum computing firm IonQ hires former JPMorgan Chase applied research head
IonQ is one of the larger examples of pure-play quantum firms; it and competitors including Rigetti and D-Wave have seen their shares surge in the past year.
Sports bar chain Twin Peaks is going public. These restaurant companies are the next to watch
IPO experts are expecting more companies to go public this year than last year, and restaurants including Panera and Fogo de Chao are considering offerings.
FTC commissioner questions status of Snap AI chatbot complaint: ‘People deserve answers’
President Trump attempted to remove Slaughter from her FTC position, but a U.S. appeals court allowed her to maintain her role.